Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis
A New Regenerative Medicine Protocol Using Autologous Bone Marrow Mononuclear Cells With Growth Factors to Treat Liver Cirrhosis
Global Stem Cell Center, Baghdad
10 participants
Feb 20, 2026
INTERVENTIONAL
Conditions
Summary
the study includes patients with liver cirrhosis irrespective of the stage excluding people with active tumor or other major health issue endangering life, the protocol includes the use of autologous bone marrow derived mononuclear cells harvested from the same patient under local anesthesia ,followed by cell concentration and viability testing , then final product is combined with small volume of 2 cc of Wharton gel exosomes 20 billion per to be administered intravenously.
Eligibility
Exclusion Criteria3
- active malignancy.
- severe sepsis.
- pregnancy. -
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
using autologous bone marrow aspirated from iliac crest ,centrifuged and then injected intravenously
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07374185